David C. Linehan

20.5k total citations · 7 hit papers
174 papers, 13.6k citations indexed

About

David C. Linehan is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, David C. Linehan has authored 174 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Oncology, 58 papers in Surgery and 53 papers in Immunology. Recurrent topics in David C. Linehan's work include Pancreatic and Hepatic Oncology Research (72 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Immune cells in cancer (26 papers). David C. Linehan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (72 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Immune cells in cancer (26 papers). David C. Linehan collaborates with scholars based in United States, Switzerland and United Kingdom. David C. Linehan's co-authors include Steven M. Strasberg, William G. Hawkins, Peter S. Goedegebuure, Jeffrey A. Drebin, Timothy J. Eberlein, David G. DeNardo, Brian A. Belt, Andrea Wang‐Gillam, Jonathan B. Mitchem and S. Peter Goedegebuure and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

David C. Linehan

165 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma

2002 1.2k citations Yoshiyuki Tanaka, Steven M. Strasberg et al. The Journal of Immunology profile →
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

2014 974 citations Yu Zhu, Brett L. Knolhoff et al. Cancer Research profile →
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

2012 759 citations Jonathan B. Mitchem, Donal J. Brennan et al. Cancer Research profile →
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

2009 641 citations David C. Linehan et al. profile →
The Accordion Severity Grading System of Surgical Complications

2009 542 citations Steven M. Strasberg, David C. Linehan et al. profile →
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

2013 479 citations Dominic E. Sanford, Brian A. Belt et al. Clinical Cancer Research profile →
Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

2022 161 citations Nicholas A. Ullman, Paul R. Burchard et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by David C. Linehan

Since Specialization

Citations

This map shows the geographic impact of David C. Linehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Linehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Linehan more than expected).

Fields of papers citing papers by David C. Linehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Linehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Linehan. The network helps show where David C. Linehan may publish in the future.

Co-authorship network of co-authors of David C. Linehan

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Linehan. A scholar is included among the top collaborators of David C. Linehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Linehan. David C. Linehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors 2024 ·Proceedings of the National Academy of Sciences ·Ankit Dahal, Yeonsun Hong, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kihong Lim, David C. Linehan, Scott A. Gerber, Minsoo Kim	12
2	Smad4 restricts injury-provoked biliary proliferation and carcinogenesis 2024 ·Disease Models & Mechanisms ·W. Brock Alexander, Wenjia Wang, Margaret Hill, Michael R. O’Dell, Luis I. Ruffolo, Bing Guo, Katherine M. Jackson, Nicholas A. Ullman, (unknown), Matthew N. McCall, (unknown), (unknown), Mary Georger, Brian A. Belt, Christa L. Whitney‐Miller, David C. Linehan, Patrick J. Murphy, Aram F. Hezel	5
3	Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot breakdown → 2022 ·Journal of Clinical Oncology ·Nicholas A. Ullman, Paul R. Burchard, Richard F. Dunne, David C. Linehan	161
4	Predictors of opioid-free discharge after laparoscopic cholecystectomy 2022 ·The American Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), David C. Linehan, Jacob Moalem	1
5	Intrathecal Morphine and Effect on Opioid Consumption and Functional Recovery after Pancreaticoduodenectomy 2022 ·Journal of the American College of Surgeons ·Paul R. Burchard, (unknown), (unknown), Anthony Loria, (unknown), Myla Strawderman, Luke O. Schoeniger, (unknown), Jacob Moalem, David C. Linehan	6
6	HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression 2021 ·The Journal of Immunology ·Rachael B. Rowswell-Turner, Rakesh K. Singh, (unknown), Naohiro Yano, Kyu Kwang Kim, (unknown), (unknown), (unknown), Virginia Hovanesian, Nicole E. James, Jennifer R. Ribeiro, Sindhuja Kadambi, David C. Linehan, Richard G. Moore	19
7	Cachexia And Cholangiocarcinoma: Implications On Prognosis And Immunomodulation 2020 ·HPB ·Luis I. Ruffolo, (unknown), (unknown), S. Joe Qin, (unknown), (unknown), (unknown), Rosalyn Jewell, Mary Georger, David C. Linehan, Pilar Prieto	1
8	Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer 2019 ·Cancer Immunology Research ·Jian Ye, Bradley N. Mills, (unknown), Booyeon J. Han, (unknown), (unknown), Carl J. Johnston, Edith M. Lord, Brian A. Belt, David C. Linehan, Scott A. Gerber	29
9	Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer 2019 ·Clinical Cancer Research ·Naim U. Rashid, Xianlu L. Peng, Chong Jin, Richard A. Moffitt, Keith E. Volmar, Brian A. Belt, Roheena Z. Panni, Timothy M. Nywening, Silvia G. Herrera, Kristin J. Moore, (unknown), Ashley B. Morrison, (unknown), Apoorve Nayyar, (unknown), Benjamin Schmidt, Han Jo Kim, David C. Linehan, Jen Jen Yeh	104
10	Enhanced recovery after surgery protocol in pancreatic surgery, critical factors for rapid patient recovery 2019 ·HPB ·Karen Pineda‐Solís, Luis I. Ruffolo, David C. Linehan, Luke O. Schoeniger, (unknown)	0
11	Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up 2017 ·HPB ·(unknown), Jingxia Liu, David C. Linehan, Marcus Tan, Benjamin Tan, Ryan C. Fields, Steven M. Strasberg, William G. Hawkins	11
12	CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models breakdown → 2014 ·Cancer Research ·Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer, Timothy M. Nywening, Brian L. West, Jingqin Luo, Andrea Wang‐Gillam, S. Peter Goedegebuure, David C. Linehan, David G. DeNardo	974
13	Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis breakdown → 2013 ·Clinical Cancer Research ·Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Allese Mayer, Anjali D. Deshpande, Danielle Carpenter, Jonathan B. Mitchem, Stacey M. Plambeck-Suess, Lori A. Worley, Brian D. Goetz, Andrea Wang‐Gillam, Timothy J. Eberlein, David G. DeNardo, S. Peter Goedegebuure, David C. Linehan	479
14	Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses breakdown → 2012 ·Cancer Research ·Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu, Dominic E. Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica‐Worms, Stephen M. Hewitt, Girish Mallya Udupi, William M. Gallagher, Craig D. Wegner, Brian L. West, Andrea Wang‐Gillam, Peter S. Goedegebuure, David C. Linehan, David G. DeNardo	759
15	Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer 2009 ·The Journal of Immunology ·Marcus Tan, Peter S. Goedegebuure, Brian A. Belt, Brian Flaherty, Narendra V. Sankpal, William E. Gillanders, Timothy J. Eberlein, Chyi‐Song Hsieh, David C. Linehan	351
16	Outcomes analysis of laparoscopic resection of pancreatic neoplasms 2006 ·Surgical Endoscopy ·Richard A. Pierce, (unknown), William G. Hawkins, Steven M. Strasberg, David C. Linehan, Valerie J. Halpin, J. Chris Eagon, L. Michael Brunt, Margaret M. Frisella, Brent D. Matthews	88
17	Induction of Antigen-Specific CTL by Recombinant HIV Trans -Activating Fusion Protein-Pulsed Human Monocyte-Derived Dendritic Cells 2003 ·The Journal of Immunology ·Yoshiyuki Tanaka, Steven F. Dowdy, David C. Linehan, Timothy J. Eberlein, Peter S. Goedegebuure	31
18	Simultaneous Production of T Helper-1-like Cytokines and Cytolytic Activity by Tumor-Specific T Cells in Ovarian and Breast Cancer 1997 ·Cellular Immunology ·Peter S. Goedegebuure, (unknown), (unknown), David C. Linehan, (unknown), Eric K. Ganguly, Timothy J. Eberlein	25
19	Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer 1995 ·The Journal of Immunology ·David C. Linehan, Peter S. Goedegebuure, George E. Peoples, (unknown), Timothy J. Eberlein	97
20	Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. 1995 ·Proceedings of the National Academy of Sciences ·George E. Peoples, Peter S. Goedegebuure, Robert W. Smith, David C. Linehan, Ichiro Yoshino, T.J. Eberlein	372

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact